I found this article at MedGadget blog today about a researcher at the Hebrew University of Jerusalem that found a way to control bacterial activity without antibiotics, he interferes with their communication process. Only recently has it been discovered that the bacteria assembled in biofilms have a network of
Primary Immunodeficiency Archive
“We cannot allow patients to die,” said Marcia Boyle, CEO and chair of the Immune Deficiency Foundation (IDF). “We have an FDA-approved lifesaving therapy that cannot be used in physicians’ offices because the MMA reduced reimbursement to the point that the medication isn’t affordable. We are counting on Sec.
More about gene therapy.. Interesting data: By GARDINER HARRIS; Published: March 3, 2005 The French study was once hailed as one of the first breakthroughs in gene therapy: 10 children suffering from a rare immune disorder were largely cured. But three of those children have since developed leukemia, and
I contacted Dr. Alain Fischer once, read message here. And his response here. FDA Halts Gene Therapy Experiments; By Rick Weiss, Washington Post Staff Writer, Thursday, March 3, 2005; 2:20 PM The Food and Drug Administration has suspended several U.S. gene therapy experiments after learning that a third child
A story from NBC News uses Dr. Orange’s words: “A person with primary immune deficiency is unable to protect themselves from even common infections,” said Dr. Jordan Orange, a pediatric immunologist. “What we’re doing with this treatment is replacing that missing part of her immune system,” Orange said. Dr.
Bacteria-Killing vs. Bacteria-Inhibiting Drugs in Treating Infections When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two. The solution is not always obvious, particularly since a drug that is bactericidal for one strain of